Cumulative probability of CIN2 stratified by HPV test results.

Slides:

Advertisements

Similar presentations

Survival Analysis-1 In Survival Analysis the outcome of interest is time to an event In Survival Analysis the outcome of interest is time to an event The.

Advertisements

Lecture 3 Survival analysis. Problem Do patients survive longer after treatment A than after treatment B? Possible solutions: –ANOVA on mean survival.

HSRP 734: Advanced Statistical Methods July 10, 2008.

Participant Characteristics by Lowest Leg AAI Category Ann M. O’Hare, et al, Circulation 2006;113;

April 18 Intro to survival analysis Le 11.1 – 11.2

Risk factors for cervical intraepithelial neoplasia recurrence after loop electrosurgical excision procedure in HIV-1-infected and non-infected women.

Odds ratios for change in PD from earliest mammogram within levels of earliest PD. No evidence for an interaction of earliest PD and change in PD on breast.

Comparison between Kaplan-Meier survival estimates of Bristol aortic valve surgery patients and the Monte Carlo-based generated Kaplan-Meier curve using.

Kaplan-Meier survival curves comparing survival between both time periods according to management strategy. Survival in patients with infective endocarditis.

Nat. Rev. Cardiol. doi: /nrcardio

Comparison of linear and log-linear general relative risk models for the association between lung cancer mortality and mean county-level residential radon.

Variability in protein concentration of urine over a 10-d collection from a single healthy volunteer. Variability in protein concentration of urine over.

Genomic DNA methylation (ng mCyt/μg DNA) according to combined MTHFR 1298A>C and 677C>T genotypes and low or high plasma folate levels (i.e., below or.

A graphing calculator is required for some problems or parts of problems 2000.

Jeffrey E. Korte, PhD BMTRY 747: Foundations of Epidemiology II

Mintu P. Turakhia et al. JACEP 2016;2:

Enrollment and Outcomes

Kaplan-Meier survival curve demonstrating treatment duration of metformin and orlistat. Kaplan-Meier survival curve demonstrating treatment duration of.

Impact of Diabetes Mellitus on the Association of Vascular Disease Before Transplantation With Long-term Transplant and Patient Outcomes After Kidney.

Characteristics of Malignant Pleural Mesothelioma in Women

Principal component analysis of adipose tissue fatty acids.

Kaplan-Meier plots of hHF: DPP-4i and SU cohort with baseline CVD (panel A); saxagliptin and sitagliptin cohorts with baseline CVD (panel B); DPP-4i and.

Kaplan-Meier survival curves for the development of diabetes by quartiles of baseline pedometer steps. Kaplan-Meier survival curves for the development.

Clinically significant precounseling cancer distress modifies counseling method's effect on testing uptake. *, statistically significant difference observed.

CAPP2: Time to first colorectal cancer in those randomized to aspirin compared with those randomized to the aspirin placebo. CAPP2: Time to first colorectal.

Kaplan-Meier curve of cumulative percentage of cardiac mortality by peak flow rate category (adjusted HRs (95% CI) compared with ≥550 L/min: (

Kaplan–Meier plots of 5 and 12-year all cause (A and C, respectively) and cardiovascular mortality (B and D, respectively) with number of participants.

A: Kaplan-Meier curves depicting the cumulative probability of CVE in patients with low (

Risk of PTC associated with serum concentrations of TSH and thyroid hormones among females, stratified by tumor size. *, Conditional logistic regression,

Christian Madelaire et al. JCHF 2018;6:

Comparison of survival in patients with BAV (A) and TAV (B) in the US cohort using Kaplan-Meier curves, stratified by whether or not they had suffered.

Survival based on V gene mutation status and CD38 expression among B-CLL patients who stratify to the Rai intermediate risk category. Survival based on.

Brand-specific incremental lifetime cancer risk subtotals: \batchmode \documentclass[fleqn,10pt,legalpaper]{article} \usepackage{amssymb} \usepackage{amsfonts}

Kaplan-Meier survival curve for CVD mortality among physically active and inactive type 2 diabetic patients stratified by baseline hs-CRP levels. Kaplan-Meier.

The power to detect an OR of 2

Scatterplot and LD map of the genotyped tagging SNPs along the TOX3/LOC region. Scatterplot and LD map of the genotyped tagging SNPs along the TOX3/LOC

Meta-analysis of five prospective studies examining the associations between urinary melatonin secretion and breast cancer risk. Meta-analysis of five.

Increased levels of branching on serum glycoproteins from patients with HCC. A, focus on larger branched glycans from 4 representative cirrhotics, and.

Risk of cervical precancerous lesions associated with high-risk HPV infection according to MAVS rs status. Risk of cervical precancerous lesions.

Relative risks of colon cancer in prospective cohort studies, comparing the highest with the lowest category of heme iron consumption. Relative risks of.

CD8, galectin-3, galectin-9, and the M1/M2 ratio are associated with a longer survival. CD8, galectin-3, galectin-9, and the M1/M2 ratio are associated.

Multivariate-adjusted breast density means for joint relation of IGF-I with IGFBP-3 in premenopausal women. Multivariate-adjusted breast density means.

Analysis of studies that examined the association between diabetes mellitus and prostate cancer. Analysis of studies that examined the association between.

Kaplan-Meier plots of the duration of continuous albuterol, time until q4 albuterol, and hospital LOS for each of the 4 treatment groups. Kaplan-Meier.

Risk (aOR) of breast cancer associated with the combination of putative at-risk genotypes of the MRN genes and the reproductive risk factors of a history.

Age-adjusted breast cancer incidence rates in females by age-adjusted HD incidence rates in females 15–34 years of age in 135 populations in the world.

Regional association plot of genotyped and imputed SNPs in proximity to rs , summarizing evidence of interaction with at least weekly heartburn or.

The I1307K APC gene variant was identified using primers designed to detect the I1307K. The I1307K APC gene variant was identified using primers designed.

Kaplan-Meier survival plot for primary endpoint of arthritis development. Kaplan-Meier survival plot for primary endpoint of arthritis development. Arthritis-free.

Kaplan–Meier curves for PFS and OS (for patients treated with anti-PD-1/PD-L1 monotherapy). Kaplan–Meier curves for PFS and OS (for patients treated with.

Parity explains the age-associated increase in ANA prevalence in women ages 12 to 59 years, but not in those ages 60+. Parity explains the age-associated.

Kaplan-Meier survival curves of the IMRS association with non-fatal stroke/mortality (stroke-free survival) in women with AF, stratified by CHA2DS2-VASc.

Gene copy number analysis by multiplexed quantitative differential PCR for BRCA1 and BRCA2 for 23 DNA specimens obtained from patients of Hispanic ancestry.

The ROC curves analyzing the sensitivity and specificity of rCBVmax values in astrocytomas for 1-year survival (A) and recurrence (B) show the optimal.

A and B, The ROC curves analyzing the sensitivity and specificity of the WHO grading system (I-IV) for the 1-year survival (A) and recurrence (B) show.

Gene promoter methylation analysis in ductal lavage fluid from cancer-free women at high risk for breast cancer and in women undergoing mastectomy for.

The percentage of positive among all women (A), women with CIN2, or more severe diagnosis (CIN2+; sensitivity; B), and grade 3 (CIN3) or more severe diagnosis.

Kaplan-Meier curve for the probability of noninvasive ventilation (NIV) failure relative to continuous use of NIV and stratified for Acute Physiology and.

Scatter plot of serum OPN levels and its correlation with patient survival. Scatter plot of serum OPN levels and its correlation with patient survival.

Association of MTR A2756G with risk of localized and advanced prostate cancer: dominant model comparing (G/G and A/G) versus A/A genotypes (I-V, inverse-variance.

GATA-3 immunostaining was scored semiquantitatively; tumors with

Whole mounts (A-D; ×20), and H&E sections (E-H, ×100) of the mammary gland. Whole mounts (A-D; ×20), and H&E sections (E-H, ×100) of the mammary gland.

Gastric, lung, and HPV-related cancer incidence and model fits.

Daniele Muser et al. JACEP 2017;j.jacep

The pattern of association between all-cancer mortality risk and long-term exposure to PM2.5 (μg/m3). The pattern of association between all-cancer mortality.

Individuals affected with cancer included in the Lynch syndrome are colored. Individuals affected with cancer included in the Lynch syndrome are colored.

Quantile–quantile plots of 42 interaction P values for seven SNPs under investigation. Quantile–quantile plots of 42 interaction P values for seven SNPs.

Pooled effect of exercise on glucose, IR, IGF1, and IGFBP3 in breast cancer survivors. Pooled effect of exercise on glucose, IR, IGF1, and IGFBP3 in breast.

Epithelial and stromal percentage clusterin staining in normal nonadjacent colonic tissue and matched tumor tissue in 202 patients with stage II colorectal.

Presentation transcript:

Cumulative probability of CIN2 stratified by HPV test results. Cumulative probability of CIN2 stratified by HPV test results. The curves exclude enrollment cases of cytologic HSIL or histologic CIN2+, to permit calculation of hazard ratios using proportional hazard methods. The numbers of women still at risk for each HPV test stratum are listed below the graph. The cumulative risk (cumulative probability) is plotted using Kaplan-Meier methods that take into account censoring due to cytologic HSIL or histologic CIN2+ or losses to follow-up. The PPV includes all cases observed combining enrollment and follow-up, but does not take into account censoring. A, women <30: HPV16 infection, cumulative probability = 10.5 (95% CI = 7.0–15.7) and PPV = 9.7 (95% CI = 7.0–12.5); Other carcinogenic types, cumulative probability = 5.9 (95% CI = 3.9–8.9), PPV = 4.9 (95% CI = 3.4–6.3); no carcinogenic types, cumulative probability = 3.1 (95% CI = 2.4–3.9) and PPV = 1.4 (95% CI = 1.1–1.6). B, women 30+: HPV16 infection, cumulative probability = 4.2 (95% CI = 1.0–17.3) and PPV = 11.0 (95% CI = 5.9–16.1); Other carcinogenic types, cumulative probability = 6.1 (95% CI = 3.7–9.8), PPV = 6.7 (95% CI = 4.4–9.0); no carcinogenic types, cumulative probability = 0.6 (95% CI = 0.4–0.9) and PPV = 0.4 (95% CI = 0.3–0.5). Mark Schiffman et al. Cancer Epidemiol Biomarkers Prev 2011;20:1398-1409 ©2011 by American Association for Cancer Research